Investor Presentation • Jun 30, 2025
Investor Presentation
Open in ViewerOpens in native device viewer
March 2025
Springer Nature is one of the leading publishers of research in the world. Through our leading brands, we provide technologyenabled products, platforms and services that help researchers to uncover new ideas and share their discoveries, health professionals to stay at the forefront of medical science, and educators to advance learning.




Note: Revenue splits FY 2024
Revenues disclosed as contracted were generated under journal and eBook contracts, 3rd party distribution deals, TAs, certain contracts in the full OA business and database business
Transactional OA (individual Article Processing Charges) c. 24%; contracted OA (e.g. Article Processing Charges from Consortia & Institutional OA agreements or Journal sponsorships) c. 3%

Note: Figures as of FY 2024 and subject to rounding 1. Number of unique authors supported by Snapp since launch 2023

Company estimates
InCites - Web of Science and Company estimates

World Bank and company estimates
UNESCO, IMF, expert interviews, market forecasts, and company estimates
OECD and company estimates
InCites - Web of Science and company estimates
6
| SEGMENT | KEY BRANDS | MARKET POSITION | GROWTH DRIVERS | |||
|---|---|---|---|---|---|---|
| RESEARCH | JOURNALS | 1 | # of top 50 impact journals | • Launch new journals • Increase customer penetration |
||
| 2 | # of articles in FOA journals | • Benefit from faster OA market growth • Expand market share |
||||
| 2 | # of journal articles | • Expand Transformative Agreements • Grow article volumes |
||||
| BOOKS | 1 | # of English-language academic books | • Accelerate print-to-e transition • Increase customer penetration |
|||
| SERVICES | by share of total research job advertisements | • Increase share of corporate customers • Leverage Nature brand for new products |
||||
| HEALTH | 1 1 |
in Germany with doctors in the Netherlands with healthcare practitioners |
• Increase share of digital revenues • Focus on medical affairs budgets |
|||
| EDUCATION | 1 2 |
in Brazil in private schools (ELT) in Mexico (K12 Curriculum) |
• Benefit from curriculum changes • Drive blended learning solutions |
7

Increase performance & efficiency while growing responsibly & sustainably
OA provides greater value to the research community
Higher visibility of OA articles compared to non-OA articles(1):
OA aligns publisher business model with value provided
✓ Publication output aligns with revenue performance
We are a pioneer and leader in OA for more than two decades
Pioneer OA publishing brand
Largest OA journal(3)
Most cited OA journal(4)
1. Springer Nature white paper "Going For Gold: Exploring The Reach And Impact Of Gold Open Access Articles In Hybrid Journals"
2. Defined as Altmetric attention; Altmetric attention is a system that tracks the attention that research outputs such as schol arly articles and datasets receive online
3. By number of articles published from 2021-2023
4. Based on the sum of total citations in 2022

Springer Nature's Article Processing Platform
Since launch, as of 31-Dec-2024
CSAT scores according to company customer survey 2024 overall
Data points as of 2024


Macmillan Education Everywhere offers a blended learning solution to schools


Medbee app supports doctors with latest guidelines at the point of care


12
Regular customer surveys confirm high satisfaction scores of 86% for journal authors, 88% for reviewers and 72% for editors(4)
1. Full PAI table available on our website.
This document,which has been prepared by Springer Nature AG & Co. KGaA (the "Company", and together with its subsidiaries, the "Group"), is for information purposesonly and must not be relied upon for any purpose. It does not purport to contain all information required to evaluate the Company or the Group and/or its financial position or prospects. This document does not, and is not intended to, constitute or form part of, and should not be construed as, an offer to sell, or a solicitation of an offer to purchase, subscribe for or otherwise acquire, any securities of the Company, nor shall it or any part of it form the basis of, or be relied upon, in connection with, or act as any inducement or recommendation for, an investment decision. The information contained in this document (the "Information") does not constitute legal, accounting, regulatory, taxation or other advice. This document is not directed at, or intended for distribution to or use by, any person or entity that is a citizen or resident or located in any locality, state, country or other jurisdiction where such distribution, public ation, availability or use would be contrary to law or regulation or which would require any registration or licensingwithinsuch jurisdiction. Persons into whose possession this document comes should inform themselves about, and observe, any such restrictions.
No representation, warranty or undertaking, express or implied, is made by the Company or any company of the Group as to, and no reliance should be placed on, the fairness, accuracy, completeness or correctness of the Information or the opinions contained therein or any other statement made or purported to be made in connection with the Company or the Group, for any purpose whatsoever, including but not limited to any investment considerations. No responsibility, obligation or liability whatsoever, whether arising in tort, contract or otherwise, is or will be accepted by the Company or any of its directors, officers, employees, shareholders, advisers or agents or any other person for any loss, cost or damage howsoever arising from any use of the Information, or for any errors, omissions or misstatements in the Information. In addition, no duty of care or otherwise is owed by the Company or any of its directors, officers, employees, shareholders, advisers or agents to recipients of the informationor any otherperson in relation to the Information.
The Information is unaudited except the information extrac ted from the audited financial statements. In providing ac cess to the Information, neitherthe Company nor any of its directors, officers, employees, shareholders, advisers or agents or any other person undertakes any obligation to provide any additional information or to update the Information or to correct any inaccuracies in any such Information, including any financial data or forward looking statements. The Information should be considered in the context of the circumstances prevailing at the time and has not been, and will not be, updated to reflect material developments which may occur afterthe date thereof.
Parts of the Information, includingmarket data and trend information, may be based on or taken from information and statistics from external sources. While the Company believes that each of these external publications, studies and surveys has been prepared by a reputable source, the Company has not independently verified the data contained therein and any inclusion herein should not be interpreted as an endorsement or as a confirmation by the Company or any other person of the accurateness of this information. All statements in this document attributable to third party industry experts represent the Company's interpretation of data, research opinion or viewpoints published by such industry experts, and have not been reviewed by them. Each public ation of such industry experts speaks as of its original publication date and not as of the date of this document. In addition, certain of the industry, market and competitive position data contained in the Information come from the Company's own internal research and estimates based on the knowledge and experience of the Company's management in the markets in which the Company and the other members of the Group operate. While the Company believes that such research and estimates are reasonable, they, and their underlying methodology and assumptions, have not been verified by any independent source for accuracy or completeness and are subject to change and correction without notice. Accordingly, reliance should not beplaced on any of the industry, market or competitive position data contained in the Information.
This document may include forward looking statements. Forward looking statements are statements that are not historical facts and may be identified by words such as "plans", "targets", "aims"," believes", "expects", "anticipates", "intends", "estimates", "will", "may", "continues", and similar expressions. These forward looking statements reflect, at the time made, the Company's beliefs, intentions and current targets/aims concerning, among other things, the Company's or the Group's results of operations, financial condition, liquidity, prospects, growth and strategies. Forward looking statements include statements regarding objectives, goals, strategies, outlook and growth prospects; future plans, events or performance and potential for future growth; liquidity, capital resources and capital expenditures; economic outlook and industry trends; developments of the Company's or the Group's markets; the impact of regulatory initiatives; and the strength of the Company's or any other member of the Group's competitors. Forward looking statements involve risks and uncertainties because they relate to events and depend on circumstances that may or may not occur in the future. The forward looking statements in the Information are based upon various assumptions, many of which are based, in turn, upon further assumptions, including without limitation, management's examination of historical operating trends, data contained in the Company's records (and those of other members of the Group) and other data available from third parties. Although the Company believes that these assumptions were reasonable when made, these assumptions are inherently subject to significant known and unknown risks, uncertainties,contingencies and otherimportant factorswhich are difficult or impossible to predict and are beyond its control.
Forward looking statements are not guarantees of future performance and such risks, uncertainties, contingencies and otherimportant factors could cause the actual outcomes and the results of operations, financial condition and liquidity of the Company and other members of the Group or the industry to differ materially from those results expressed or implied in the Information by such forward looking statements. No representation or warranty is made that any of these forward looking statements or forecasts will come to pass or that any forecast result will be achieved. Undue influence should not be givento, and no relianceshould beplaced on, any forward looking statement.
This document includes certain alternative financial measures not presented in accordance with IFRS. These financial measures are not measures of financial performance in accordance with IFRS and may exclude items that are significant in understanding and assessing the Company's financialresults. They may not be comparable to similarly titled measures presented by other companies, which may bedefined and calculated differently, and should not be considered in isolation or as an alternative to financial measures determined in ac cordance with IFRS. You are cautioned not to place reliance on any non-IFRS financial measures, adjustments thereto and ratios included herein.
Have a question? We'll get back to you promptly.